Incyte Reports 2017 Second-Quarter Financial Results and Updates on Key Clinical Programs

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/26/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. NDAQ
9. TSCO
10. BE

Go back to Incyte Reports 2017 Second-Quarter Financial Results and Updates on Key Clinical Programs

Incyte (INCY) Misses Q2 EPS by 3c, Sales Beat; Raises FY17 Jakafi Revenue Outlook

August 1, 2017 7:11 AM EDT

Incyte (NASDAQ: INCY) reported Q2 EPS of ($0.06), $0.03 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $326.44 million versus the consensus estimate of $315.4 million.

Raises Jakafi net product revenues guidance for 2017 to $1.09-$1.112B versus $1.02-$1.07 billion... More